Gene therapy in monogenic congenital myopathies - Université d'Évry Access content directly
Journal Articles Methods Year : 2016

Gene therapy in monogenic congenital myopathies


Current treatment options for patients with monogenetic congenital myopathies (MCM) ameliorate the symptoms of the disorder without resolving the underlying cause. However, gene therapies are being developed where the mutated or deficient gene target is replaced. Preclinical findings in animal models appear promising, as illustrated by gene replacement for X-linked myotubular myopathy (XLMTM) in canine and murine models. Prospective applications and approaches to gene replacement therapy, using these disorders as examples, are discussed in this review.

Dates and versions

hal-02180076 , version 1 (11-07-2019)



Xuan Guan, Melissa Goddard, David Mack, Martin K. Childers. Gene therapy in monogenic congenital myopathies. Methods, 2016, 99, pp.91-98. ⟨10.1016/j.ymeth.2015.10.004⟩. ⟨hal-02180076⟩
29 View
0 Download



Gmail Facebook X LinkedIn More